This registry will collect and validate regulatory-grade real-world data (RWD) on the usage of the LPS-Adsorber and the outcomes from using the LPS-Adsorber in various patient populations (various sub-registries) that also have suspected endotoxemia. This data can be then used in real-world evidence (RWE) generation. It will also create reusable infrastructure to allow creation or affiliation with many additional RWD/RWE efforts both prospective and retrospective in nature.
Study Type
OBSERVATIONAL
LPS Adsorber, binding endotoxin caused by suspected or verified gram-negative bacteria.
The primary endpoint will be the time needed to achieve patient stabilization from the time of treatment.
Time frame: 30 days
Secondary Outcomes will be to document the change in a patient's symptoms of infection over time.
Time frame: 30 days
Rate of complaints and incidents related to the medical device during the whole registry.
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.